HC Wainwright & Co. Reiterates Buy on HilleVax, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Matthew Caufield has reiterated a Buy rating on HilleVax (NASDAQ:HLVX) with a maintained price target of $28.

May 10, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirms a Buy rating on HilleVax, with a price target of $28, indicating a positive outlook on the stock.
The reiteration of a Buy rating by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's future performance. Maintaining a $28 price target suggests that the analyst sees substantial upside potential from the current trading levels, which could positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100